Our oncologists are located in the consultancy rooms in Suite 1.
Dr Islam has interests and skills in treating lung cancer, head and neck cancer, colorectal cancer, breast cancer, prostate cancer and other urogenital cancers. He is involved in research at Tasman Health Care and also at Gold Coast University Hospital where he is a Principal Investigator and Sub-Investigator on a number of clinical trials.
Prior to commencing specialist training, Dr Islam practiced medicine for over 12 years and across three different countries and speaks multiple languages. Dr Islam also has valuable cross-cultural communication skills and insights into diverse medical systems.
working in a number of research facilities including
QIMR and teaching hospitals such as Guy’s and St
Thomas in London.
She has experience in Phase I trials, breast, gynecology,
urology and lung cancers, with a particular interest in the
psychological aspects of oncology. Dr Allan
enjoys working with geriatric, adolescent and youth
He is involved in the multidisciplinary meetings for breast cancer, urological cancers, gastrointestinal disease and palliative care. His main interests are in the treatment of melanoma, castrate-resistant prostate, gastrointestinal and breast cancers. He is an investigator in multiple clinical trials.
He completed his Specialist Medical Oncology training in Queensland across multiple hospitals including The Royal Brisbane and Women’s Hospital, Mater Hospital Brisbane and Princess Alexandra Hospital in 2016. Prior to that, Dr Bajaj undertook basic physician training at The Gold Coast Hospital.
He has strong interest and expertise in treating colon, lung, genito-urinary, melanoma and breast cancer with a focus on biological, targeted treatment and immunotherapies. Dr Bajaj has been actively involved in research projects during his training program and has a strong interest in clinical trials involving solid cancers. He is co-investigator for multiple clinical trials with Tasman Oncology Research, enrolling patients in clinical trials for melanoma and other solid organ malignancies.